Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Impediments to drug development.

Martin C Robson1

  • 1Institute of Tissue Regeneration, Repair, and Rehabilitation, Bay Pines, and the Department of Surgery, University of South Florida, Tampa, Florida, USA. mcrobson@earthlink.net

Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society
|May 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost-Effectiveness of Hypochlorous Acid Preserved Wound Cleanser versus Saline Irrigation in Conjunction with Ultrasonic Debridement for Complex Wounds.

Journal of health economics and outcomes research·2021
Same author

Hypochlorous Acid Solution Is Safe for Intracavitary Lavage: Examination in a Rodent Model.

Eplasty·2021
Same author

Primum non nocere: A therapeutic imperative for modern wound care.

Bulletin of the American College of Surgeons·2017
Same author

The Immediate and Delayed Post-Debridement Effects on Tissue Bacterial Wound Counts of Hypochlorous Acid Versus Saline Irrigation in Chronic Wounds.

Eplasty·2017
Same author

In vitro microbicidal, anti-biofilm and cytotoxic effects of different commercial antiseptics.

International wound journal·2016
Same author

Reduction of a multidrug-resistant pathogen and associated virulence factors in a burn wound infection model: further understanding of the effectiveness of a hydroconductive dressing.

Eplasty·2014

Developing new wound care products faces significant hurdles. Overcoming challenges in cost, regulation, and reimbursement is crucial for translating scientific advances into patient treatments.

Area of Science:

  • Biotechnology
  • Pharmaceutical Sciences
  • Wound Healing Research

Background:

  • Continuous need for novel wound care products and improved patient outcomes.
  • Significant investment by pharmaceutical and biotechnology industries in wound healing research.
  • Limited understanding of drug development impediments among the public and healthcare providers.

Purpose of the Study:

  • To identify and elucidate the multifaceted impediments in the drug development pipeline for wound healing.
  • To highlight the gap between scientific advancement and clinical application in wound care.
  • To advocate for improved interaction between research, industry, and regulatory bodies.

Main Methods:

  • Review of existing literature on drug development processes and challenges.

Related Experiment Videos

  • Analysis of economic, regulatory, and reimbursement factors impacting pharmaceutical innovation.
  • Identification of barriers in translating scientific findings into marketable wound care products.
  • Main Results:

    • Key impediments include high costs, short patent lifecycles, regulatory hurdles, and high attrition rates during clinical trials.
    • Reimbursement issues, particularly for the elderly population with chronic wounds, present a significant barrier.
    • Lack of a unified voice and collaboration between academic societies, government agencies, and industry hinders progress.

    Conclusions:

    • Translating scientific discoveries into effective wound care products requires addressing numerous complex challenges.
    • Enhanced collaboration and streamlined processes are essential to overcome development barriers.
    • Facilitating the transition of scientific innovation to patient bedside care is paramount for improving quality of life.